# Prosperico Ventures

> Prosperico Ventures is a VC fund in Shanghai backing Medical and Health Care. See 16 investments, round sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 16
- Last investment: Jun 2026
- Lead investor: 25%
- Last updated: Aug 2026
- Website: http://www.prosperico-venture.com/

Prosperico Ventures is a venture capital firm focused on healthcare and the high-tech industry.

## Contacts

5 contacts available for Prosperico Ventures. Shizune tracks 1 team members at Prosperico Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/prosperico-ventures?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $4.3M–$60M |
| Series B | $9.2M–$150M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 8 | 50% |
| Health Care | 7 | 44% |
| Biotechnology | 6 | 38% |
| Medical Device | 3 | 19% |
| Dental | 1 | 6% |

17 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 8 | 50% |
| Seed | 3 | 19% |
| Series B | 3 | 19% |
| Series C | 1 | 6% |
| Corporate Round | 1 | 6% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 11 | 69% |
| United States | 1 | 6% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Tingzhi Qian | President, Founding Partner | 1 | https://shizune.co/investors/profile/tingzhi-qian |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Antekin Biotech | Antekin Biotech is a leading vaccine company with integrated capabilities spanning the entire vaccine value chain, from research and development to manufacturing and commercialization. The company is dedicated to advancing innovative vaccine technologies, enhancing disease prevention, and delivering high-quality vaccine solutions to improve publichealth and address global healthcare challenges. | $143.2M | Corporate Round | Jun 15, 2026 |  |
| Yingte Micro Network | Yingte Micro Network is a medical device company focused on advancing innovation in energy-based therapeutic platforms and minimally invasive interventions, dedicated to improving patient outcomes through cutting-edge technology, precision engineering, and clinically proven solutions that enhance safety, efficiency, and recovery in modernhealthcare. |  | Seed | Apr 07, 2026 |  |
| Cytocares | Cytocares offers innovative drug design for antibody novel medication creation and development in the realm of tumor immunity. | $14.4M | Series A | May 13, 2023 |  |
| Jiaohong Biology | Jiaohong Biology is a molecular diagnostic technology research and development and application service provider. |  | Seed | Jan 20, 2023 |  |
| KingstronBio | KingstronBio manufactures artificial heart valves and annuloplasty rings. | $47M | Series C | Nov 19, 2021 |  |
| Singlera Genomics | Singlera Genomics is a fast growing company focusing on non-invasive genetic testing. Singlera’s main products and services include tumor diagnosis and personalized treatment, non-invasive prenatal diagnosis, pre-implantation genetic screening, and customized scientific research services. Singlera is dedicated to the development of precisionmedicine, striving to help the patients through early, accurate and informative diagnoses. | $150M | Series B | Dec 15, 2020 |  |
| Silexon | Silexon is an AI drug research and development service provider. It is committed to the systematic integration of drug big data using artificial intelligence methods, and deep-enhanced drug development process, specifically involving drug target panorama report, personalized cell therapy, and small molecule virtual screening. |  | Series A | Oct 17, 2019 |  |
| Sealmed | Its main business scope is medical device technology development and sales; biomedical technology development, technology transfer, technical consulting services; corporate marketing planning; market research; business information consulting; Management consulting services; self-operated and agent import and export business of various commoditiesand technologies. |  | Series A | Sep 16, 2019 |  |
| InfiNovo | Infinovo was formed in 2016. For the past several years, Infinovo has been focusing on developing an accurate and affordable CGM (Continuous Glucose Monitoring) for patients which will be available for both Type 1 and Type 2 Diabeties. The company has developed a CGM which can compete in the global market for accuracy, durability, and design. |  | Series A | Apr 01, 2019 |  |
| Wolfman Medical Technology (Forssmann) | Wolfman Medical Technology is a medical imaging equipment developer dedicated to medical imaging technology and brain |  | Seed | Oct 16, 2018 |  |

10 of 16 investments shown.

## Co-investors
- [BioVenture](https://shizune.co/investors/profile/bioventure) — VC Fund, 2 deals together
- [Cowin Capital](https://shizune.co/investors/profile/cowin-capital) — VC Fund, 2 deals together
- [Furong Capital](https://shizune.co/investors/profile/furong-capital) — VC Fund, 2 deals together
- [Green Pine Capital Partners](https://shizune.co/investors/profile/green-pine-capital-partners) — VC Fund, 2 deals together
- [Bossage Genetics](https://shizune.co/investors/profile/bossage-genetics) — VC Fund, 1 deal together
- [China Resources Pharmaceutical Industry Investment Fund](https://shizune.co/investors/profile/china-resources-pharmaceutical-industry-investment-fund) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Medical Device VC Funds in China](https://shizune.co/investors/medical-device-vc-funds-china)

## FAQ

### What does Prosperico Ventures invest in?

Prosperico Ventures invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Seed stage. Most of the 16 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What round sizes does Prosperico Ventures invest in?

Prosperico Ventures typically joins rounds of $4.3M–$60M at Series A and $9.2M–$150M at Series B. These are whole funding-round sizes, not Prosperico Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Prosperico Ventures took part in.

### How do I contact Prosperico Ventures?

Public channels for Prosperico Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Prosperico Ventures?

The team at Prosperico Ventures includes Tingzhi Qian (President, Founding Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co